"Time to Market Quality Products for unmet Medical Needs" – "Time to Market Quality Products for unmet Medical Needs"

Our strategy is time to market for affordability, accessibility, and availability for equitable distribution of medicines for unmet needs.

Pharmaceuticals 👆

Biologics

Biosimilar

Vaccines

Genomic Diagnostics

Research & Devolopment
Products
Services

PHARMACEUTICALS

Reasearch & Devolopment

We are developing innovative NDA’s & ANDA’s for in licensing & out licensing.
Partnering with Global Companies.
Developing Nano Technology, Micronization, & extended release.

Products

API’s & Bulk Drugs
ANDA Formulations
Specialty Drugs
Oncology
Infectious Diseases

VACCINES

Reasearch & Devolopment

The company developed innovative proprietary cell line platform “Novacell” (an embryonic derived Stem Cells) for producing pure, high titer (potent) and cost-effective viral vaccines (preventable and therapeutic).
We have developed robust cGMP manufacturing technology with high purity than the currently available traditional vaccine manufacturers.

Products

Vaccines for preventive and therapeutic category :

Infectious Diseases
- Viral Platform
- Bacterial Platform
Oncolytic Virus Platform
mRNA Covid – 19 Universal Vaccine
Viral Vector Platform (AAV & BV)
BV driven VLP Platform

BIOLOGICS

Reasearch & Devolopment

We developed Novacell proprietary platform technology for producing Innovative biologics for affordable, accessible and timely available products.

We are developing highly immunogenic antibodies in a proprietary technology (Specific Binding and Highly Immunogenic and effective) .

Products

Therapeutic Proteins
Gene Therapy
Monoclonal Antibodies
Polyclonal Antibodies

BIOSIMILARS

Reasearch & Devolopment

Our Focus is to develop therapeutics for diabetics, cancer and infectious diseases.

Our team has the vision for commercial launch of novel Bio-Drugs, Biosimilars using manufacturing Platform Technologies (E coli, Yeast, Mammalian (CHO), Egg Embryonic, Insect cell (SF9) culture technologies). Our team has also direct hands-on experience in using these platform technologies and made biological drugs in 60,000 liters bioreactors and 1000-2000 liters of disposable single use systems (Upstream & Downstream) cost effectively and reduced time to commercial launch.

Products

Insulin & Insulin Analogs
Monoclonal Antibodies (MABS)
Conjugated Vaccines

Genomic Diagnostics

Genomic Diagnostics is a DBA of ABS Inc., headquartered in New Jersey, USA and operations in Pennsylvanian. We have been conducting research, product development, manufactures bacterial and viral diagnostic kits, reagents, reference standards for medical diagnostic applications.